26choiceM

Dow Jones vs. S&P 500: What UnitedHealth’s volatility reveals for investors

Charu Chanana 400x400
Charu Chanana

Chief Investment Strategist

Key points:

  • UnitedHealth volatility highlights a key difference between the Dow and the S&P 500. UnitedHealth’s sharp decline and subsequent rebound had an outsized impact on the Dow, while the S&P 500 remained relatively unaffected, underscoring how index structure drives performance sensitivity.
  • The Dow is price-weighted; the S&P 500 is market-cap weighted. In the Dow, high-priced stocks like UNH can disproportionately move the index, even when most other components are flat or rising. In contrast, the S&P 500 spreads influence across a broader base, muting the effect of individual stock swings.
  • For long-term investors, the S&P 500 offers diversified, growth-oriented exposure while Dow offers a defensive tilt. The Dow’s construction makes it more sensitive to moves in a few names but also gives it a tilt toward value and defensive sectors—making it useful as a tactical complement in more volatile or late-cycle environments.


Note: This content is marketing material.

 

Last week, UnitedHealth Group (UNH) took center stage in U.S. equity markets—not for its gains, but for a sharp selloff that sent the stock nearly 23% lower. The move weighed heavily on the Dow Jones Industrial Average, where UNH holds significant influence due to the index’s price-weighted methodology.

The episode serves as a timely reminder of the structural differences between the Dow Jones and the S&P 500—and why understanding those differences is critical for investors making allocation decisions.

Why did UnitedHealth fall?

The stock declined sharply amid a convergence of negative developments:

  • Reports emerged that the U.S. Department of Justice had launched a criminal investigation into UnitedHealth’s Medicare Advantage billing practices.
  • The company withdrew its 2025 financial guidance, citing rising medical costs, particularly from newer Medicare Advantage patients.
  • The abrupt resignation of CEO Andrew Witty added to investor concerns and led to a broader selloff.

The stock ended the week down 23%, with most of the damage occurring on 13 May, when UNH fell 18% in a single day. You can read more about the great UnitedHealth collapse in this article: How a healthcare titan lost 54% in weeks

Why index construction matters

UnitedHealth is a constituent of both the Dow Jones Industrial Average and the S&P 500, but the way these indices are constructed means the impact of UNH’s moves is felt very differently.

The Dow is price-weighted, meaning a stock’s influence is based on its share price. UNH is one of the highest-priced stocks in the index, so large moves in its share price can swing the Dow significantly. On 13 May, despite half the Dow’s components closing higher, the index still fell around 270 points—with UNH accounting for over 400 points of downward pressure, according to our estimates.

By contrast, the S&P 500 is market-cap weighted, which spreads exposure more broadly across sectors and companies. While UNH’s sharp drop was felt, the S&P 500 still managed to close up 0.7%, lifted by gains in large-cap tech names. Notably, more than half of the index’s components ended the day in the red—underscoring how market-cap weighting can mute the impact of single-stock declines.

This dynamic played out in reverse just days later. On 19 May, UNH rebounded strongly—rising 8.2% in a single session. The Dow, with its heavy price-based exposure to UNH, gained 0.3%. The S&P 500, however, rose only 0.09%, again illustrating how index structure influences performance.


Index construction at a glance

Dow Jones Industrial Average

  • Composed of 30 large-cap U.S. companies.
  • Price-weighted: higher-priced stocks carry more index weight.
  • Tilts toward healthcare, industrials, and financials.
  • Highly sensitive to single-stock moves, as demonstrated by UNH’s drag.

S&P 500

  • Composed of 500 large-cap U.S. companies.
  • Market-cap weighted: larger companies by value have more influence.
  • Heavily weighted in tech and growth sectors.
  • Better represents broad market sentiment and reduces concentration risk.

Strategic implications for investors

Impact of individual stocks:

  • Due to the DJIA's price-weighted structure, high-priced stocks like UNH can disproportionately influence the index's performance.
  • The S&P 500's market-cap weighting dilutes the impact of any single stock, offering more diversified exposure.

Sector rotation considerations:

  • If there's a market rotation from technology to sectors like healthcare, the DJIA may benefit more due to its sector composition.
  • Investors anticipating such rotations might consider increasing exposure to the DJIA or sector-specific ETFs.
  • But in a tech-led rally, the S&P 500 is likely to lead.

Diversification and stability:

  • The S&P 500's broader base provides more stability and is less susceptible to volatility from individual stock movements.
  • For long-term investors seeking diversified exposure, the S&P 500 remains a foundational choice.
  • Holding both indices, or using ETFs that balance between value and growth sectors, may help navigate volatility and sector rotations more effectively.

Portfolio allocation considerations

Short-term tactical moves:

Investors looking to capitalize on potential rebounds in specific sectors, like healthcare, might consider targeted investments in the DJIA or sector-specific ETFs.

Long-term stability:

Maintaining a core allocation to the S&P 500 ensures broad market exposure and mitigates risks associated with individual stock volatility.

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992